Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-controlled, double-blind, combined dose-finding and proof-of-concept trial with parallel-group design in postmenopausal women
This research study is looking into a new treatment for a common condition called vaginal atrophy, which can affect women after menopause. This condition can cause symptoms like dryness, itching, and discomfort. The study is testing a new vaginal ring that slowly releases a hormone called estriol at three different doses. We want to find out if this new ring helps improve vaginal health and which dose is most effective. Some women will receive a ring with no active medicine (a placebo) to help researchers understand the true effects of the new treatment. This is a crucial step in developing new and better options for managing these symptoms.
At a glance
What is this study about?
You're probably here because you've heard about a study looking into a new treatment for vaginal dryness and discomfort, often called vaginal atrophy. This is a very common issue for women after menopause, and it happens when there's a drop in certain hormones, leading to changes in the vaginal tissues.
This particular study is focusing on a new type of treatment: a vaginal ring. This ring is designed to slowly release a low dose of a hormone called estriol directly into the vagina. The idea is that providing this hormone can help restore the natural health of the vaginal tissues and relieve symptoms like dryness, itching, and pain during sex. Researchers are testing three different doses of this ring – a very low dose, a medium dose, and a slightly higher dose – to see which one works best and is safest.
The study also includes a 'placebo' group. This means some women will receive a vaginal ring that looks exactly like the treatment rings but doesn't contain any active medicine. This is very important in medical research because it helps doctors understand if the improvements seen are truly due to the medicine or if they might be due to other factors. All participants will be monitored closely, and the study aims to gather important information that could lead to new treatment options for women experiencing these symptoms.
Key takeaways
- The study tests a new vaginal ring for postmenopausal vaginal dryness.
- It compares three different doses of the ring with a placebo (dummy ring).
- The goal is to find the most effective and safe dose of the new treatment.
- Participation involves using the ring for 90 days and attending clinic visits.
- All information is kept confidential.
- Your participation helps advance understanding of treatments for vaginal atrophy.
Who may be eligible?
To be considered for this study, you need to be a woman who has gone through menopause. There isn't an upper age limit, so women of many different ages can take part, as long as they are 18 years or older.
The research team will need to check some things to make sure the study is a good fit for you and that it would be safe for you to participate. This will involve reviewing your medical history and current health.
It's important to remember that even if you meet these general criteria, there might be other specific health conditions or medications that would prevent you from joining. This is to ensure everyone's safety and to make sure the study results are clear.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a woman who has gone through menopause?
- Are you 18 years old or older?
- Are you able to attend appointments at the study clinic?
- Are you comfortable using a vaginal ring?
What does participation involve?
If you decide to take part in this study, you would use a vaginal ring for a period of 90 days (about 3 months). During this time, you would have several visits to the clinic so the research team can check how you're doing and if the treatment is working. They will take some measurements to look at the health of your vaginal tissues, such as checking cell types and pH levels. You wouldn't know if you're receiving the active drug or the placebo, and neither would the study doctors – this is called "double-blind" and helps make the results more reliable. After the 90 days, there will be a follow-up to see how you're doing. The total time you'd be involved in the study, including follow-up, would likely be a few months.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is 'vaginal atrophy'?
It's a common condition after menopause where vaginal tissues become drier, thinner, and less elastic, causing discomfort.
What is a 'placebo'?
A placebo is a dummy treatment that looks like the real medicine but contains no active drug. It helps researchers see if the real drug is effective.
What does 'double-blind' mean?
It means neither you nor your study doctor will know if you're getting the active treatment or the placebo. This helps prevent bias.
How long will I be in the study?
You'll use the vaginal ring for 90 days, with follow-up appointments, meaning your total involvement will likely be a few months.
Can I leave the study if I change my mind?
Yes, you can withdraw from the study at any time, for any reason, without it affecting your regular medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.